On a project it is hoped could help speed the development of new vaccines and of anti-cancer drugs

On a project it is hoped could help speed the development of new vaccines and of anti-cancer drugs
DeepMatter (AIM: DMTR), the AIM-quoted company focusing on digitising chemistry, has been selected as a partner for the University of Leeds following a £1.4M EPSRC investment they received to develop